Clinical Trials Browser

Recruiting × OTHER × Arthritis, Rheumatoid × Clear all

Arthritis, Rheumatoid

NCT04751396 2025-11-10

Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors

Arthritis, Rheumatoid, Autoimmune Diseases, Colitis, Ulcerative, Crohn Disease, Lupus Erythematosus, Systemic, Melanoma, Psoriasis, Spondylitis, Ankylosing, Inflammatory Bowel Diseases, Arthritis, Psoriatic, Arthritis, Reactive

NCT06831994 2025-06-29

Digital Implementation of the German S3 Clinical Practice Guideline for Multimorbidity

Phase NA Recruiting

660 enrolled

BreastOther

Arthritis, Rheumatoid, Breast Neoplasms, Coronary Disease, Depression, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Heart Failure, Obesity, Osteoporosis, Pulmonary Disease, Chronic Obstructive

NCT03987633 2025-03-10

EMPOWER

Recruiting

200,000 enrolled

GenitourinaryOtherThoracic

Ischemic Stroke, Arthritis, Rheumatoid, Asthma, Atrial Fibrillation, Mental Disorders, Cardiovascular Diseases, Coronary Disease, Dementia, Depression, Diabetes Mellitus, Epilepsy, Heart Failure, Hypertension, Lung Neoplasms, Neoplasms, Obesity, Prostatic Neoplasms, Pulmonary Disease, Chronic Obstructive, Renal Insufficiency, Chronic, Peripheral Arterial Disease

NCT03976245 2024-11-29

Advanced Therapeutics in Rheumatoid Arthritis (RA)

Phase 4 Recruiting

144 enrolled

Arthritis, Rheumatoid

NCT04731831 2024-06-28

Characterization of Immunogenicity of TNF Inhibitors in Arthritis Patients With Poorer Treatment Response.

Recruiting

120 enrolled

Arthritis, Rheumatoid, Spondylitis, Ankylosing, Arthritis, Psoriatic

Clinical Trials

RA-DRUM

Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors

Digital Implementation of the German S3 Clinical Practice Guideline for Multimorbidity

EMPOWER

Advanced Therapeutics in Rheumatoid Arthritis (RA)

Characterization of Immunogenicity of TNF Inhibitors in Arthritis Patients With Poorer Treatment Response.